Gastroretentive Delivery Systems: A Mini Review

References

• Rouge N., Buri P., Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site‐specific delivery. Int. J. Pharm. 1996; 136: 117–139
   Web of Science ®Google Scholar
• Fell J. T., Whitehead L., Collet H. Prolonged gastric retention using floating dosage forms. Pharm. Technol. 2000; 24(3)82–90
   Google Scholar
• Matharu R. S., Sanghavi N. M. Novel drug delivery system for captopril. Drug Dev. Ind. Pharm. 1992; 18: 1567–1574
   Web of Science ®Google Scholar
• Fell J. T. Delivery systems for targeting to specific sites in the gastrointestinal tract. J. Pharm. Pharmacol. 1999; 51(Suppl)41
   PubMedGoogle Scholar
• Baumgartner S., Kristl J., Vrecer F., Vodopivec P., Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. 2000; 195(1–2)125–135
   PubMed Web of Science ®Google Scholar
• Deshpande A. A., Rhodes C. T., Shah N. H., Malick A. W. Controlled‐release drug delivery systems for prolonged gastric residence: an overview. Drug Dev. Ind. Pharm. 1996; 22(6)531–539
   Web of Science ®Google Scholar
• Ateshkadi A., Lam N., Johnson C. A. Clin. Pharm. 1993; 12: 34–48
   PubMedGoogle Scholar
• Chatterjee A., Yasmin T., Bagchi D., Stohs S. J. The bactericidal effects of lactobacillus acidophilus, garcinol, and protykin compared to clarithromycin on Helicobacter Pylori. Mol. Cell. Biochem. 2003; 243(1–2)29–35
   PubMed Web of Science ®Google Scholar
• Menon A., Wolfgang A., Ritschel A., Sakr A. Development of and evaluation of a monolithic floating dosage form for furosemide. J. Pharm. Sci. 1994; 83: 239–245
   PubMed Web of Science ®Google Scholar
• Rubinstein A. Microbially controlled drug delivery to the colon. Biopharm. Drug Dispos. 1990; 11: 465–475
   PubMed Web of Science ®Google Scholar
• Dressman J. B., Berardi R. R., Dermentzoglou L. C., Russell T. L., Schmaltz S. P., Barnett J. L., Jarvenpaa K. M. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm. Res. 1990; 7: 756–761
   PubMed Web of Science ®Google Scholar
• Russell T. L., Berardi R. R., Barnett J. L., Dermentzoglou L. C., Jarvenpaa K. M., Schmaltz S. P., Dressman J. B. Upper gastrointestinal pH in seventy‐nine healthy, elderly, North American men and women. Pharm. Res. 1993; 10(2)187–196
   PubMed Web of Science ®Google Scholar
• Lui C. Y., Amidon G. L., Berardi R. R., Fleisher D., Youngberg C., Dressman J. B. Comparison of gastrointestinal pH in dog and humans: implications on the use of the beagle dog as a model for oral absorption in humans. J. Pharm. Sci. 1986; 75: 271–274
   PubMed Web of Science ®Google Scholar
• Mojaverian P., Chan K. K.H. (a). Radiotelemetric determination of gastrointestinal pH, in vitro accuracy and in vivo reproducibility in man. Pharm. Res. 1988; 5: S‐243
   Google Scholar
• Feldman M., Barnett C. Dig. Dis. Sci. 1991; 36: 866–869
   PubMed Web of Science ®Google Scholar
• Charman W. N., Porter J. H., Mithani S., Dressman J. B. Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J. Pharm. Sci. 1997; 86(3)269–282
   PubMed Web of Science ®Google Scholar
• Varis K., IHamaki T., Harkonen M., Samlof I. M., Siruala M. Gastric morphology, function, and immunology in first‐degree relatives of probands with pernicious anemia and controls. Scand. J. Gastroenterol. 1979; 14(2)129–139
   PubMed Web of Science ®Google Scholar
• Holt P. R., Rosenberg H., Russell R. M. Causes and consequences of hypochlorhydria in elderly. Dig. Dis. Sci. 1989; 34(6)933–937
   PubMed Web of Science ®Google Scholar
• Lake‐Bakaar G., Quadros E., Beidas S., Elaskr M., Tom W., Wilson D., Dinscoy H. P., Cohen P., Straus E. W. Ann. Intern. Med. 1988; 112: 502–504
   Google Scholar
• Benn A., Cooke W. T. Intraluminal pH of duodenum and jejunum in fasting subjects with normal and abnormal gastric or pancreatic function. Scand. J. Gastroenterol. 1971; 6: 313–317
   PubMed Web of Science ®Google Scholar
• Mojaverian P., Chan K. K.H., Desai A., John V. Gatrointestinal transit of a solid indigestible capsule as measured by radiotelemetry and dual gamma scintigraphy. Pharm. Res. 1989; 6: 719–724
   PubMed Web of Science ®Google Scholar
• Evans D. F., Pye G., Bramley R., Clark A. G., Dyson T. J., Hardcastle J. D. Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 1988; 29: 1035–1041
   PubMed Web of Science ®Google Scholar
• Fell J. T. Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract. J. Anat. 1996; 189: 517–519
   PubMed Web of Science ®Google Scholar
• Sarna S. K. Cyclic motor activity: migrating motor complex. Gastroenterology 1985; 89: 894–913
   PubMed Web of Science ®Google Scholar
• Rubinstein A., Li V. H.K., Robinson J. R. Gastrointestinal‐physiological variables affecting performance of oral sustained release dosage forms. Oral Sustained Release Formulations: Design and Evaluation, A. Yacobi, W. E. Halperin. New York, Pergamon. 1988, (Chapter 6)
   Google Scholar
• Schemann M., Ehlein H. J. Mechanical characterstics of phase II and phase II of the interdigestive migrating motor complex in dogs. Gastroenterology 1986; 91: 117–123
   PubMed Web of Science ®Google Scholar
• Wilding I. R., Coupe A. J., Davis S. S. The role of γ‐scintigraphy in oral drug delivery. Adv. Drug Deliv. Rev. 1991; 7: 87–117
   Web of Science ®Google Scholar
• Shargel L., Yu A. Applied Biopharmaceutics and Pharmacokinetics4th Ed. Appleton and Lange, Philadelphia 1999
   Google Scholar
• Hofmann A. F., Pressman J. H., Code C. F., Witztum K. F. Controlled entry of orally administered drugs: physiological considerations. Drug Dev. Ind. Pharm. 1983; 9(7)1077–1109
   Web of Science ®Google Scholar
• Kutchai H. C. The gastrointestinal system. Principles of Physiology2nd Ed., R. M. Berne, M. N. Levy. Mosby Year Book, St. Louis, MO 1996; 652–686
   Google Scholar
• Haus L. C., Fell J. T. Effect of stress on the gastric emptying of capsules. J. Clin. Hosp. Pharm. 1984; 9: 249–251
   PubMedGoogle Scholar
• Reddy S. M., Sinha V. R., Reddy D. S. Novel oral colon‐specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs. Drugs Today 1999; 35(7)537–580
   PubMed Web of Science ®Google Scholar
• Ollerenshaw K. J., Norman S., Wilson C. G., Hardy J. G. Exercise and small intestinal transit. Nucl. Med. Commun. 1987; 8: 105–110
   PubMed Web of Science ®Google Scholar
• Mojaverian P., Vlasses P. H., Kellner P. E., Rocci M. L. Effects of gender, posture, and age on gastric residence time of an indigestible solid: Pharmaceutical considerations. Pharm. Res. 1988; 5(10)639–643
   PubMed Web of Science ®Google Scholar
• Kinget R., Kalala W., Vervoort L., Mooter G. V. Colonic drug targeting. J. Drug Target. 1998; 6(2)129–149
   PubMed Web of Science ®Google Scholar
• Davis S. S., Khosla R., Wilson C. G., Washington N. The gastrointestinal transit of a controlled release pellet formulation of tiaprofenic acid. Int. J. Pharm. 1987; 35: 253–258
   Web of Science ®Google Scholar
• Park H. M., Chernish J. M., Rosenbeck B. D., Brunelle R. L., Hargrove B., Wellman H. N. Gastric emptying of enteric coated tablets. Dig. Dis. Sci. 1984; 29: 207–212
   PubMed Web of Science ®Google Scholar
• Coupe A. J., Davis S. S., Wilding I. R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res. 1991; 8(3)360–364
   PubMed Web of Science ®Google Scholar
• Khosla R., Feely L. C., Davis S. S. Gastrointestinal transit of non‐disintegrating tablets in fed subjects. Int. J. Pharm. 1989; 53: 107–117
   Web of Science ®Google Scholar
• Davis S. S., Hardy G. J., Taylor M. J., Whalley D. R., Wilson C. G. The effect of food on the gastrointestinal transit of pellets and an osmotic device (Osmet). Int. J. Pharm. 1984; 21: 331–340
   Web of Science ®Google Scholar
• Hunter E., Fell J. T., Sharma H. The gastric emptying of pellets contained in hard gelatin capsules. Drug Dev. Ind. Pharm. 1982; 8: 751–757
   Web of Science ®Google Scholar
• Marvola M., Aito H., Ponto P., Kanniksoki A., Nykanen S., Kokkonen P. Gastrointestinal transit and concomitant absorption of verapamil from single unit sustained released tablet. Drug Dev. Ind. Pharm. 1987; 13: 1593–1609
   Web of Science ®Google Scholar
• Ch'ng H. S., Park H., Kelly P., Robinson J. R. Bioadhesive polymers as platforms for oral controlled drug delivery. II. Synthesis and evaluation of some swelling, water insoluble polymers. J. Pharm. Sci. 1985; 74(4)399–405
   PubMed Web of Science ®Google Scholar
• Longer M. A., Ch'ng H. S., Robinson J. R. Bioadhesive polymers as platforms for oral controlled drug delivery. III. Oral delivery of Chlorothiazide using bioadhesive polymers. J. Phar. Sci. 1985; 74(4)406–411
   PubMed Web of Science ®Google Scholar
• Park K., Robinson J. Bioadhesive polymers as platform for oral‐controlled drug delivery: method to study bioadhesion. Int. J. Pharm. 1984; 19(1)107–127
   Google Scholar
• Smart J. D., Kellaway I. W. Pharmaceutical factors influencing the rate of gastrointestinal transit in an animal model. Intl. J. Pharm. 1989; 53: 79–83
   Google Scholar
• Sakkinen M., Linna A., Ojala S., Jurjenson H., Veski P., Marvola M. In vivo evaluation of matrix granules containing microcrystalline chitosan as a gel forming excipient. Int. J. Pharm. 2003; 250(1)227–237
   PubMedGoogle Scholar
• De la torro P. M., Torrado S., Torrado S. Interpolymer complexes of poly(acrylic acid) and chitosan: influence of the ionic hydrogel‐forming medium. Biomaterials 2003; 24(8)1459–1468
   PubMed Web of Science ®Google Scholar
• Preda M., Leucuta S. E. Oxprenolol‐loaded bioadhesive microspheres: preparation and in vitro/in vivo characterization. J. Microencapsul 2003; 20(6)777–789
   PubMed Web of Science ®Google Scholar
• Kikendall J. W., Friedman A. C., Oyewole M. A., Fleischer D., Johnson L. F. Pill‐induced esophageal injury. Case reports and review of the medical literature. Dig. Dis. Sci. 1983; 28: 174–182
   PubMed Web of Science ®Google Scholar
• Agyilirah G. A., Green M., duCret R. Evaluation of gastric retention properties of a cross‐linked polymer‐coated tablet versus those of a nondisintegrating tablet. Int. J. Pharm. 1991; 75: 241–247
   Web of Science ®Google Scholar
• Bechgaard H., Baggesen S. Propoxyphene and norpropoxyphene: influence of type of controlled release formulation on intra‐and inter‐subject variations. J. Pharm. Sci. 1980; 69(11)1327–1330
   PubMed Web of Science ®Google Scholar
• Devereux J. E., Newton J. M., Short M. B. The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol. 1990; 42: 500–501
   PubMed Web of Science ®Google Scholar
• Clarke G. M., Newton J. M., Short M. B. Comparative gastrointestinal transit of pellet systems of varying desnsity. Int. J. Pharm. 1995; 114(1)1–11
   Google Scholar
• Davis S. S., Stockwell A. F., Taylor M. J., Hardy J. G., Whalley D. R., Wilson C. G., Bechgaard H. F.N. Christensen, the effect of density on the gastric emptying of single‐and multiple‐unit dosage forms. Pharm. Res. 1986; 3(4)208
   PubMed Web of Science ®Google Scholar
• Sugito K., Ogata H., Goto H., Noguchi M., Kogure T., Takano M., Maruyama Y., Sasaki Y. Gastrointestinal transit of non‐disintegrating silid formulations in humans. Int. J. Pharm. 1990; 60: 89–97
   Web of Science ®Google Scholar
• Seth P. R., Tossounian J. L. Sustained Release Pharmaceutical Capsules. US Patent 4126672, November 1978
   Google Scholar
• Seth P. R., Tossounian J. L. Novel Sustained Release Tablet Formulations. US Patent 4167558, September 1979
   Google Scholar
• Watanabe S., Kayano M., Ishino Y., Miyao K. Solid Therapeutic Preparation Remaining in the Stomach. US Patent 3976764, August 1976
   Google Scholar
• Harrigan R. M. Drug Delivery Device for Preventing Contact of Undissoved Drug with the Stomach Lining. US Patent 4055178, October 1977
   Google Scholar
• Michaels A. S., Bashaw J. D., Zaffaroni A. Gastro‐Inflatable Drug Delivery Device. US Patent 3901232, 1975
   Google Scholar
• Stockwell A. F., Davis S. S., Walker S. E. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Control. Release 1986; 3: 167–175
   Google Scholar
• Ichikawa M., Watanabe S., Miyake Y. A new multiple‐unit oral floating dosage system. I. Preparation and in vitro evaluation of floating and sustained release characteristics. J. Pharm. Sci. 1991; 80: 1062–1066
   PubMed Web of Science ®Google Scholar
• Baumgartner S., Kristl J., Vrecer F., Vodopivec P., Zorko B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. 2000; 195(1–2)125–135
   PubMed Web of Science ®Google Scholar
• Oth M., Franz M., Timmermans J., Moes A. The bilayer floating capsule: a stomach‐directed drug delivery system for Misoprostol. Pharm. Res. 1992; 9(3)298–302
   PubMed Web of Science ®Google Scholar
• Young L., Fassihi R. Zero‐order release kinetics from a self correctable floatable asymmetric configuration drug delivery system. J. Pharm. Sci. 1996; 85: 170–173
   PubMed Web of Science ®Google Scholar
• Kawashima Y., Niwa T., Takechi H., Hino T., Itoth Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci. 1992; 81: 135–140
   PubMed Web of Science ®Google Scholar
• El‐Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non‐floating chitosan microspheres. Int. J. Pharm. 2002; 249(1)7–21
   PubMedGoogle Scholar
• Streubel A., Siepmann J., Bodmeier R. Floating microparticles based on low density foam powder. Int. J. Pharm. 2002; 241(2)279–292
   PubMed Web of Science ®Google Scholar
• Struebel A., Siepmann J., Bodmeier R. Multiple units gastroretentive drug delivery systems: a new preparation method for low density microparticles. J. Microencapsul. 2003; 20(3)329–347
   PubMed Web of Science ®Google Scholar
• Sato Y., Kawashima Y., Takeuchi H., Yamamoto H. In vivo evaluation of riboflavin‐containing microbaloons for floating controlled drug delivery system in healthy human volunteers. J. Control. Release 2003; 93(1)39–47
   PubMed Web of Science ®Google Scholar
• Atyabi F. H.L., Sharma H. A.H., Mohammed T. J. Fell, in vivo evaluation of novel gastric retentive formulation based on ion‐exchange resins. J. Control. Release 1996; 42(2)105–113
   Web of Science ®Google Scholar
• Burton S., Washington N., Steele R. J.C., Musson R., Feely L. Intragastric distribution of ion‐exchange resins: a drug delivery system for the topical treatment of the gastric mucosa. J. Pharm. Pharmacol. 1995; 47(11)901–906
   PubMed Web of Science ®Google Scholar
• Whitehead L., Fell J. T., Collett J. H., Sharma H. L., Smith A. M. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J. Control. Release 1998; 55(1)3–12
   PubMed Web of Science ®Google Scholar
• Whitehead L., Collett J. H., Fell J. T. Amoxicillin release from a floating dosage form based on alginates. Int. J. Pharm. 2000; 210: 45–49
   PubMed Web of Science ®Google Scholar
• Jackson S. J., Perkins A. C. In vitro assessment of the mucoadhesion of cholestyramine to procine and human gastric mucosa. Eur. J. Pharm. Biopharm. 2001; 52(2)121–127
   PubMed Web of Science ®Google Scholar
• Umamaheshwari R. B., Jain S., Jain N. K. A new approach in gastroretentive drug delivery system using cholestyramine. Drug Deliv. 2003; 10(3)151–160
   PubMed Web of Science ®Google Scholar
• Groning R., Heun C. Oral dosage forms with controlled gastrointestinal transit. Drug Dev. Ind. Pharm. 1984; 10(4)527–539
   Web of Science ®Google Scholar
• Cargill R. I., Caldwell J., Engle K. J., Fix A., Porter P. A., Gardner C. R. Controlled gastric emptying. I. Effects of physical properties on gastric residence times of non‐disintegrating geometric shapes in beagle dogs. Pharm. Res. 1988; 5(8)533–536
   PubMed Web of Science ®Google Scholar
• Cargill R., Engle K., Gardner C. R., Porter P., Sparer R. V., Fix J. A. Controlled gastric emptying. II. In vitro erosion and gastric residence times of an erodible device in beagle dogs. Pharm. Res. 1989; 6(6)506–509
   PubMed Web of Science ®Google Scholar
• Klausner E. A., Lavy E., Stepensky D., Friedman M., Hoffman A. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm. Res. 2002; 19(10)1516–1523
   PubMed Web of Science ®Google Scholar
• Klausner E. A., Eyal S., Lavy E., Friedman M., Hoffman A. Novel levodopa gastroretentive dosage form: in vivo evaluation in dogs. J. Control. Release 2003; 88(1)117–126
   PubMed Web of Science ®Google Scholar